Showing results (701-710 of 826) with videos related to

Sort By:
Pageof 83
Plos Pathogens|April 5, 2019
Gut microbiota from high-risk men who have sex with men drive immune activation in gnotobiotic mice and in vitro HIV infectionSam X Li, Sharon Sen, Jennifer M Schneider, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Toward Overcoming Staphylococcus aureus Aminoglycoside Resistance Mechanisms with a Functionally Designed Neomycin AnalogueStephen Hanessian, Alexandre Giguère, Justyna Grzyb, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 20, 2018
The North-South Divide: Substance Use Risk, Care Engagement, and Viral Suppression Among Hospitalized Human Immunodeficiency Virus-Infected Patients in 11 US CitiesMorgan M Philbin, Daniel J Feaster, Lauren Gooden, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 31, 2025
Evaluation of brachytherapy applicators and their association with morbidity and local control in cervix cancer: An EMBRACE I analysisM Serban, S Spampinato, A de Leeuw, et al.
Gynecologic Oncology|August 17, 2020
Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging - An analysis from the EMBRACE studyJ Knoth, R Pötter, I M Jürgenliemk-Schulz, et al.
The Lancet. Oncology|May 5, 2012
Phase 2 trial design in neuro-oncology revisited: a report from the RANO groupEvanthia Galanis, Wenting Wu, Timothy Cloughesy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 2025
Long-acting cabotegravir/rilpivirine, lenacapavir, and ibalizumab use among persons with HIV-1 viremia at a Ryan White-funded clinic in the urban U.S. SouthJonathan A Colasanti, Amalia Aldredge, Larisa V Niles-Carnes, et al.
Antimicrobial Agents and Chemotherapy|September 1, 2010
Synthesis and spectrum of the neoglycoside ACHN-490James B Aggen, Eliana S Armstrong, Adam A Goldblum, et al.
The Lancet. Respiratory Medicine|June 6, 2022
The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trialStephen M Stick, Alexia Foti, Robert S Ware, et al.
The Lancet. Oncology|February 3, 2020
Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative reportTerri S Armstrong, Linda Dirven, David Arons, et al.
Pageof 83